Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Intangibles: 2017-2024

Historic Intangibles for Nutex Health (NUTX) over the last 6 years, with FY2024 value amounting to $15.5 million.

  • Nutex Health's Intangibles rose 1365.67% to $21.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.6 million, marking a year-over-year increase of 1365.67%. This contributed to the annual value of $15.5 million for FY2024, which is 2429.06% down from last year.
  • As of FY2024, Nutex Health's Intangibles stood at $15.5 million, which was down 2429.06% from $20.5 million recorded in FY2023.
  • In the past 5 years, Nutex Health's Intangibles registered a high of $22.4 million during FY2022, and its lowest value of $682649.0 during FY2021.
  • In the last 4 years, Nutex Health's Intangibles had a median value of $18.0 million in 2023 and averaged $14.8 million.
  • Its Intangibles has fluctuated over the past 5 years, first soared by 317410.56% in 2022, then plummeted by 2429.06% in 2024.
  • Annual analysis of 4 years shows Nutex Health's Intangibles stood at $682649.0 in 2021, then soared by 3174.11% to $22.4 million in 2022, then decreased by 8.22% to $20.5 million in 2023, then fell by 24.29% to $15.5 million in 2024.
  • Its Intangibles stands at $15.5 million for FY2024, versus $20.5 million for FY2023 and $22.4 million for FY2022.